Insoles are removable shoe inserts that cushion or support the foot or add sensation underfoot, used for foot pain, diabetic foot sores, and steadiness. The strongest evidence, from several controlled trials, covers intense training (fewer overuse bone cracks) and heel pain (relief at two to three months, not one year). Evidence for balance, falls, knee arthritis, and back pain is mixed. Known harms are modest and mostly minor. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Foot pain rating (0–10 scale) | Lowest tolerable; drop of at least 2 points or 30% from baseline | Tracks the main symptom target |
| Protective sensation (10-gram monofilament test) | All tested sites felt | Detects sensation loss that raises ulcer risk |
| Peak plantar pressure (in-shoe) | At least 20% below baseline; some clinics target under 200 kilopascals | Confirms pressure relief works |
| Ankle-brachial index | 1.0–1.3 | Screens for reduced leg blood flow before pressure devices |
| Hemoglobin A1c | 4.8–5.4% | Diabetes control influences neuropathy and ulcer risk |
| Timed Up and Go test | 10 seconds or less | Screens mobility and fall risk |
| Usual gait speed | 1.2 meters per second or faster | Predicts function and falls |
| Single-leg stance time (eyes open) | 30 seconds or more under age 70; 15 seconds or more in the 70s | Measures balance |
| Toe and intrinsic foot strength | No established target; track change from own baseline | Tracks possible disuse with long-term orthosis use |
Cadence: About 2 weeks after fitting for comfort and skin checks, 6–12 weeks for pain outcomes, and every 6–12 months for function and device wear; in high-risk diabetic feet, skin and foot checks every 1–3 months with in-shoe pressure re-evaluation about 6 months after fitting